
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Analysis and validation of m6A regulatory network: a novel circBACH2/has-miR-944/HNRNPC axis in breast cancer progression
Wenchang Lv, Yufang Tan, Mingchen Xiong, et al.
Journal of Translational Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 42
Wenchang Lv, Yufang Tan, Mingchen Xiong, et al.
Journal of Translational Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 42
Showing 1-25 of 42 citing articles:
The roles and mechanism of m6A RNA methylation regulators in cancer immunity
Lu Chen, Ying He, Jinyu Zhu, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 163, pp. 114839-114839
Open Access | Times Cited: 100
Lu Chen, Ying He, Jinyu Zhu, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 163, pp. 114839-114839
Open Access | Times Cited: 100
Mechanisms of immune checkpoint inhibitors: insights into the regulation of circular RNAS involved in cancer hallmarks
Lingjiao Meng, Haotian Wu, Jiaxiang Wu, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 59
Lingjiao Meng, Haotian Wu, Jiaxiang Wu, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 59
METTL14-dependent maturation of pri-miR-17 regulates mitochondrial homeostasis and induces chemoresistance in colorectal cancer
Kangyue Sun, Lu Chen, Yiwen Li, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 2
Open Access | Times Cited: 30
Kangyue Sun, Lu Chen, Yiwen Li, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 2
Open Access | Times Cited: 30
Circular RNA-mediated miRNA sponge & RNA binding protein in biological modulation of breast cancer
Jing Zhu, Qian Li, Zhongping Wu, et al.
Non-coding RNA Research (2024) Vol. 9, Iss. 1, pp. 262-276
Open Access | Times Cited: 10
Jing Zhu, Qian Li, Zhongping Wu, et al.
Non-coding RNA Research (2024) Vol. 9, Iss. 1, pp. 262-276
Open Access | Times Cited: 10
m6A readers, writers, erasers, and the m6A epitranscriptome in breast cancer
Belinda J. Petri, Carolyn M. Klinge
Journal of Molecular Endocrinology (2022) Vol. 70, Iss. 2
Open Access | Times Cited: 32
Belinda J. Petri, Carolyn M. Klinge
Journal of Molecular Endocrinology (2022) Vol. 70, Iss. 2
Open Access | Times Cited: 32
The critical roles of m6A RNA methylation in lung cancer: from mechanism to prognosis and therapy
Mei-Ning Diao, Xiao‐Jing Zhang, Yinfeng Zhang
British Journal of Cancer (2023) Vol. 129, Iss. 1, pp. 8-23
Open Access | Times Cited: 19
Mei-Ning Diao, Xiao‐Jing Zhang, Yinfeng Zhang
British Journal of Cancer (2023) Vol. 129, Iss. 1, pp. 8-23
Open Access | Times Cited: 19
microRNA-944 inhibits breast cancer cell proliferation and promotes cell apoptosis by reducing SPP1 through inactivating the PI3K/Akt pathway
Ying Zhang, Shan Li, Xiangguo Cui, et al.
APOPTOSIS (2023) Vol. 28, Iss. 11-12, pp. 1546-1563
Closed Access | Times Cited: 19
Ying Zhang, Shan Li, Xiangguo Cui, et al.
APOPTOSIS (2023) Vol. 28, Iss. 11-12, pp. 1546-1563
Closed Access | Times Cited: 19
Potential therapeutic strategy for cancer: Multi-dimensional cross-talk between circRNAs and parental genes
Xiaoyu Sun, Xinyi Zhao, Yan Xu, et al.
Cancer Letters (2024) Vol. 588, pp. 216794-216794
Closed Access | Times Cited: 8
Xiaoyu Sun, Xinyi Zhao, Yan Xu, et al.
Cancer Letters (2024) Vol. 588, pp. 216794-216794
Closed Access | Times Cited: 8
Qiang Zhou, Wei Song, Xianhui Li, et al.
Environmental Toxicology (2024) Vol. 39, Iss. 5, pp. 2893-2907
Closed Access | Times Cited: 6
The m6A reader HNRNPC promotes glioma progression by enhancing the stability of IRAK1 mRNA through the MAPK pathway
Junjun Chen, Tianzhu Lu, Tao Wang, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 6
Open Access | Times Cited: 5
Junjun Chen, Tianzhu Lu, Tao Wang, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 6
Open Access | Times Cited: 5
Unraveling the cross‐talk between N6 ‐methyladenosine modification and non‐coding RNAs in breast cancer: Mechanisms and clinical implications
Xuan Liu, Xuelong Xie, Chentao Sui, et al.
International Journal of Cancer (2024) Vol. 154, Iss. 11, pp. 1877-1889
Closed Access | Times Cited: 4
Xuan Liu, Xuelong Xie, Chentao Sui, et al.
International Journal of Cancer (2024) Vol. 154, Iss. 11, pp. 1877-1889
Closed Access | Times Cited: 4
circZNF707 promoted glycolysis and tumor progression through miR-668-3p-PFKM axis in NSCLC
Wei Chen, Shuai Fang, Xianqiao Wu, et al.
European journal of medical research (2025) Vol. 30, Iss. 1
Open Access
Wei Chen, Shuai Fang, Xianqiao Wu, et al.
European journal of medical research (2025) Vol. 30, Iss. 1
Open Access
HNRNPC promotes progression of non-small cell lung cancer by maintaining TFAP2A mRNA stability
Minghua Liao, Chunyu Li, Rui Yang, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Minghua Liao, Chunyu Li, Rui Yang, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
BTB domain and CNC homolog 2: A master regulator that controls immune response and cancer progression
Chenyang Li, Wei Lu, Han Zhang
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189325-189325
Open Access
Chenyang Li, Wei Lu, Han Zhang
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189325-189325
Open Access
Harnessing engineered extracellular vesicles for enhanced therapeutic efficacy: advancements in cancer immunotherapy
Zheng Gong, Cheng Cheng, Chaonan Sun, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access
Zheng Gong, Cheng Cheng, Chaonan Sun, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access
Novel Insights into miR-944 in Cancer
Jinze Shen, Qurui Wang, Chenhao Liang, et al.
Cancers (2022) Vol. 14, Iss. 17, pp. 4232-4232
Open Access | Times Cited: 18
Jinze Shen, Qurui Wang, Chenhao Liang, et al.
Cancers (2022) Vol. 14, Iss. 17, pp. 4232-4232
Open Access | Times Cited: 18
Crosstalk between Methylation and ncRNAs in Breast Cancer: Therapeutic and Diagnostic Implications
Yitong Liu, Ping Leng, Yan Liu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 15759-15759
Open Access | Times Cited: 16
Yitong Liu, Ping Leng, Yan Liu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 15759-15759
Open Access | Times Cited: 16
Circular RNA circ_KIAA1429 accelerates hepatocellular carcinoma progression via the miR-133a-3p/high mobility group AT-hook 2 (HMGA2) axis in an m6A-dependent manner
Chunpeng Zhang, Xinying Huang
Human Cell (2023) Vol. 36, Iss. 5, pp. 1741-1754
Closed Access | Times Cited: 10
Chunpeng Zhang, Xinying Huang
Human Cell (2023) Vol. 36, Iss. 5, pp. 1741-1754
Closed Access | Times Cited: 10
RNA-binding proteins in breast cancer: Biological implications and therapeutic opportunities
Shimeng Wang, Hexing Sun, Guan‐Yuan Chen, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 195, pp. 104271-104271
Open Access | Times Cited: 3
Shimeng Wang, Hexing Sun, Guan‐Yuan Chen, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 195, pp. 104271-104271
Open Access | Times Cited: 3
YTHDF1’s Regulatory Involvement in Breast Cancer Prognosis, Immunity, and the ceRNA Network
Wenting Luo, Youjia Zhou, Jiayang Wang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1879-1879
Open Access | Times Cited: 3
Wenting Luo, Youjia Zhou, Jiayang Wang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1879-1879
Open Access | Times Cited: 3
Cross-talk between circRNAs and m6A modifications in solid tumors
Fenfang Liu, Wendong Gu, Yingjie Shao
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Fenfang Liu, Wendong Gu, Yingjie Shao
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
N6-Methyladenosine methylation modification in breast cancer: current insights
Guangwen Zhang, Cheng Chen, Xinle Wang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Guangwen Zhang, Cheng Chen, Xinle Wang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Dual effects of circRNA in thyroid and breast cancer
Rina Guo, Rui Zhang
Clinical & Translational Oncology (2023) Vol. 25, Iss. 12, pp. 3321-3331
Closed Access | Times Cited: 7
Rina Guo, Rui Zhang
Clinical & Translational Oncology (2023) Vol. 25, Iss. 12, pp. 3321-3331
Closed Access | Times Cited: 7
Non-coding RNA-Mediated N6-Methyladenosine (m6A) deposition: A pivotal regulator of cancer, impacting key signaling pathways in carcinogenesis and therapy response
Mehrdad Hashemi, Padideh Daneii, Mohammad Arad Zandieh, et al.
Non-coding RNA Research (2023) Vol. 9, Iss. 1, pp. 84-104
Open Access | Times Cited: 7
Mehrdad Hashemi, Padideh Daneii, Mohammad Arad Zandieh, et al.
Non-coding RNA Research (2023) Vol. 9, Iss. 1, pp. 84-104
Open Access | Times Cited: 7
Epitranscriptomic orchestrations: Unveiling the regulatory paradigm of m6A, A‐to‐I editing, and m5C in breast cancer via long noncoding RNAs and microRNAs
Qinan Yin, Zhifeng Qu, Regina Mathew, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 3
Closed Access | Times Cited: 2
Qinan Yin, Zhifeng Qu, Regina Mathew, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 3
Closed Access | Times Cited: 2